Trubion: A Step Ahead of Evolution

Trubion Get Adobe Flash player

Latest News

Upcoming Events

Trubion is a biopharmaceutical company focused on the discovery, development and commercialization of novel medicines to treat inflammatory disease and cancer. Its lead product candidate, TRU-015, was named to R&D Directions’ “100 Greatest Investigational Drugs” list.